21 November 2019

The grant application called "aiREAD – Accurate and Intelligent Reading for EArlier breast cancer Detection” by project leader Ioannis Sechopoulos, has been selected for funding under the NWO TTW – KWF Kankerbestrijding – Top Sector LSH Partnership “Technology for Oncology II”.

By developing and applying new artificial intelligence methods, and advancing our knowledge on human visual perception of medical images, the investigators will improve how radiologists read breast cancer screening mammograms. Optimal reading of the screening mammograms will result in earlier detection of breast cancer, fewer healthy women recalled due to false alarms, and savings in the costs of healthcare.

Lead by Ioannis Sechopoulos, the project team consists of Jonas Teuwen, from the Department of Radiology and Nuclear Medicine, Mireille Broeders (Department for Health Evidence and the Dutch Expert Centre for Screening, LRCB), Ruud Pijnappel (UMC Utrecht and LRCB), Lucien Duijm (Canisius Wilhelmina Hospital and LRCB), and Craig Abbey and Miguel Eckstein (both from University of California, Santa Barbara, USA).

Read more on the NWO website (in Dutch).

Ioannis Sechopoulos is a member of theme Women's cancers and the LRCB, and leader of the AXTI laboratory.

Related news items


Rob Aarnoutse is appointed as professor in Translation pharmacology of antimicrobial agents in particular drugs for tuberculosis

25 January 2021

Hospital pharmacist and clinical pharmacologist Rob Aarnoutse is appointed as professor in ‘Translation pharmacology of antimicrobial agents, in particular drugs for tuberculosis’ at Radboud University / Radboudumc, starting 16 November 2020.

read more

Oral health research makes significant impact at the 148th WHO Executive Board meeting

25 January 2021

During the 148th session of the World Health Organization (WHO) Executive Board meeting, Member States passed a game-changing resolution on oral health. WHO Director General Dr Tedros Adhanom Ghebreyesus called it a “landmark resolution”.

read more

Radboud Young Academy safeguards the future of science

21 January 2021

New platform to provide advice on policy, create an interdisciplinary network of early career scientists, and promote career development.

read more

Increase radio- and immunotherapy efficacy by targeting hypoxia

21 January 2021

In a paper recently accepted by Clinical Cancer Research, Daan Boreel, together with Paul Span, Sandra Heskamp, Gosse Adema and Jan Bussink, reviews the therapeutic potential of decreasing the lack of oxygen (hypoxia) often found in solid tumors.

read more

Radiation boost lowers risk of prostate cancer recurrence

21 January 2021

An additional external-beam radiation dose delivered directly to the tumor can benefit the prospects of men with non-metastatic prostate cancer, without causing additional side effects. The risk of relapse within five years for these men is smaller than for men who did not receive this boost.

read more

New research through grants for Radboudumc researchers

14 January 2021

Several researchers at the Radboudumc have received grants to start new studies, including on rare diseases, liver disease and cancer metastases. These are grants from the Dutch Research Council, European Joint Programme on Rare Diseases and the Gastric Liver Disease Foundation.

read more